Increase in Number of Shares and Votes in Vicore Pharma
STOCKHOLM, SE / ACCESS Newswire / November 28, 2025 / Vicore Pharma Holding AB (publ) (STO: VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) today announced that the number of shares and …